Federal Circuit affirms PTAB’s Baxter ruling

The US Court of Appeals for the Federal Circuit has affirmed decisions from the Patent Trial and Appeal Board (PTAB), knocking out two Baxter patents.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

MedTech

Boston Scientific overturns $42m patent verdict on appeal

28 July 2026 Years of litigation over biodegradable drug-delivery technology took another turn after the Federal Circuit delivered a significant win for the medical device maker.

MedTech

AbbVie, Allergan takes on Swiss aesthetics rival over syringe design

23 July 2026 The latest clash between two facial aesthetics rivals centres on a Swiss rival’s newly approved syringe, which AbbVie and Allergan claim infringes five US design patents.

MedTech

UPC upholds injunction in Invisalign maker’s software dispute with rival

9 July 2026 China-headquartered Angelalign failed to convince UPC appellate judges to overturn a ban that affects its ability to offer orthodontic planning software in Europe with certain functionality.